STONEPINE CAPITAL MANAGEMENT, LLC

other names
  • STONEPINE CAPITAL MANAGEMENT, LLC

Adviser Profile

Exempt Reporting Adviser

2B(3)- PF>150mn act solely as an adviser to private funds but you are no longer eligible to check box 2.B.(2) because you have assets under management, as defined in rule 203(m)-1, in the United States of $150 million or more

Private Fund GAV* 0 -100%
SMA’s No
Private Funds 0 1

Private Funds

Employees

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck Ticker78464A870 Stock NameSPDR SERIES TRUST (PUT) $ Position$51,092,000 % Position20.00% $ Change # Change
Stck Ticker78464A870 Stock NameSPDR SERIES TRUST (CALL) $ Position$51,092,000 % Position20.00% $ Change # Change
Stck Ticker92337C203 Stock NameVERASTEM INC $ Position$17,502,190 % Position7.00% $ Change-17.00% # Change21.00%
Stck Ticker88032L605 Stock NameTENAX THERAPEUTICS INC $ Position$15,593,448 % Position6.00% $ Change10664.00% # Change8106.00%
Stck Ticker000899104 Stock NameADMA BIOLOGICS INC (CALL) $ Position$10,361,500 % Position4.00% $ Change # Change
Stck Ticker30052C107 Stock NameEVOLUS INC $ Position$7,229,864 % Position3.00% $ Change-33.00% # Change8.00%
Stck Ticker000899104 Stock NameADMA BIOLOGICS INC $ Position$6,667,400 % Position3.00% $ Change-51.00% # Change0.00%
Stck Ticker880881107 Stock NameTERNS PHARMACEUTICALS INC (CALL) $ Position$5,272,000 % Position2.00% $ Change # Change
Stck Ticker640268306 Stock NameNEKTAR THERAPEUTICS $ Position$6,115,750 % Position2.00% $ Change70.00% # Change0.00%
Stck Ticker13463J101 Stock NameCAMP4 THERAPEUTICS CORP $ Position$6,128,233 % Position2.00% $ Change337.00% # Change507.00%